COX-2 expression in uterine carcinosarcoma

References

• Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83:493–501.
   PubMed Web of Science ®Google Scholar
• Hinz B, Brune K. Cyclooxygenase-2–10 years later. J Pharmacol Exp Ther. 2002;300:367–75.
   PubMed Web of Science ®Google Scholar
• Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Expression of cyclooxygenase 1 and -2 in human colorectal cancer. Cancer Res. 1995;55:3785–9.
   PubMed Web of Science ®Google Scholar
• Denkert C, Winzer KJ, Hauptman S. Prognostic impact of cyclooxygenase-2 in breast cancer. Clin Breast Cancer. 2004;4:428–33.
   PubMedGoogle Scholar
• Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K, Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res. 2008;14:8221–7.
   PubMed Web of Science ®Google Scholar
• Munkarah A, Ali-Fehmi R. COX-2: a protein with an active role in gynecological cancers. Curr Opin Obstet Gynecol. 2005;17:49–53.
   Google Scholar
• Erkanli S, Bolat F, Kayaselcuk F, Demirhan B, Kuscu E. COX-2 and survivin are overexpressed and positively correlated in endometrial carcinoma. Gynecol Oncol. 2007;104:320–5.
   Google Scholar
• Li W, Xu RJ, Zhang HH, Jiang LH. Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer. 2006;16:1673–8.
   Google Scholar
• Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Ruangvejvorachai P, Thorner PS, Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis. Gynecol Oncol. 2009;112:241–7.
   Google Scholar
• Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT, Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Gynecol Oncol. 2008;110:445–51.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Sarian LO, Andrade LA, Pignataro F, Pinto GA, Derchain SF, Cell proliferation activity unrelated to COX-2 expression in ovarian tumors. Int J Gynecol Cancer. 2007;17:607–14.
   PubMed Web of Science ®Google Scholar
• Lee JS, Choi YD, Lee JH, Nam JH, Choi C, Lee MC, Expression of cyclooxygenase-2 in epithelial ovarian tumors and its relation to vascular endothelial growth factor and p53 expression. Int J Gynecol Cancer. 2006;16:247–53.
   Google Scholar
• Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Cosio S, The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases, Eur J Gynecol. Oncol. 2002;23:295–9.
   Google Scholar
• Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA. Prognostic features of surgical stage I carcinosarcoma. Am J Surg Path. 2007;31:1653–61.
   Google Scholar
• Matsumoto Y, Ishiko O, Sumi T, Yoshida H, Deguchi M, Nakagawa E, Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions. Oncol Rep. 2001;8:1225–7.
   Google Scholar
• Raspollini MR, Susini T, Amunni G, Paglierani M, Taddei A, Marchionni M, COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? Gynecol Oncol. 2005;96:159–67.
   PubMed Web of Science ®Google Scholar
• Cimbaluk D, Rotmensch J, Scudiere J, Gown A, Bitterman P, Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets. Gynecol Oncol. 2007;105:138–44.
   PubMedGoogle Scholar
• Semczuk A, Scomra D, Chyzynska M, Szewczuk W, Olcha P, Korobowicz E. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report. Pathol Res Pract. 2008;204:203–7.
   Google Scholar
• McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002;12:687–90.
   PubMed Web of Science ®Google Scholar
• Orejuela FJ, Ramondetta LM, Smith J, Brown J, Lemos LB, Li Y, Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Gynecol Oncol. 2005;97:483–8.
   Google Scholar
• Uotila PJ, Erkkola RU, Klemi PJ. The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma. Ann Med. 2002;34:428–33.
   PubMed Web of Science ®Google Scholar
• Abargel A, Avinoach I, Kravtsov V Boaz M, Glezerman M, Menczer J. Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma. Int J Gynecol Cancer. 2004;14:354–9.
   Google Scholar
• Bamberger AM, Riethdorf L, Milde-Langosch K, Bamberger CM, Thuneke I, Erdmann I, Strongly reduced expression of the cell cycle inhibitor p27 in endometrial neoplasia. Virchows Arch. 1999;434:423–8.
   Google Scholar
• Liao Z, Mason KA, Milas L. Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? Drugs. 2007;67:821–45.
   Google Scholar